May Hill Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
May Hill Capital's VRTX Position: Q2 2026 in Review
May Hill Capital increased its Vertex Pharmaceuticals (VRTX) stake by 8.1% in Q2 2026, buying an estimated $20.4K and bringing the position to 617 shares worth $306K. The position accounts for 0.06% of the portfolio, ranked #182.
May Hill Capital first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $307K in Q1 2025. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- May Hill Capital held 617 shares of Vertex Pharmaceuticals worth $306K as of Q2 2026.
- May Hill Capital bought 46 Vertex Pharmaceuticals shares in Q2 2026, an estimated $20.4K.
- Vertex Pharmaceuticals made up 0.06% of May Hill Capital's portfolio in Q2 2026, its #182 holding.
- May Hill Capital first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
- May Hill Capital's Vertex Pharmaceuticals position peaked at $307K in Q1 2025.
- 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on May Hill Capital's 13F filing for Q2 2026, filed 7 Aug 2026.